Xxxxxxxx, M. [The doctor's role in discrimination. What you don't know will hurt the patient] [in Danish]. Lægens xxxxx i forskelsbehandling. Det du ikke ved får patienten ondt af. Presentation. Odense, 2020:16-8.
Xxxxxxxx, M. D. v. Elan Corporation, plc, et al., Civ. Action No. 04- 11594-RWZ (hereinafter the “Civil Action”).
Xxxxxxxx, M. Xxxxxx, X.; Xxxxxxxx, X., Ceramide synthesis in the epidermis. Biochim. Biophys. Acta 2014, 1841 (3), 422-34.
Xxxxxxxx, M. D.); a second member shall be selected by RTI, and a third member shall be mutually selected by the parties hereto. The meeting policies of the TRAB shall provide that all meetings of the TRAB shall be called upon 30 days notice, absent a written waiver of notice by all TRAB members.
3.4 On a yearly basis, the TRAB shall establish Tissue Recovery Benchmarks for AOC Tissue Recovery Division. AOC Tissue Recovery Division shall use its best reasonable efforts to meet the Tissue Recovery Benchmarks. All Tissues supplied by AOC Tissue Recovery Division to RTI shall meet or exceed RTI's recovery requirements as set forth in the specifications provided to AOC Tissue Recovery Division by RTI from time to time.
3.5 AOC Tissue Recovery Division shall be entitled to a Bonus up to a maximum of $25,000 per quarter,as calculated by RTI and approved by TRAB in accordance with the provisions of Exhibit 3.5 hereof.
3.6 RTI shall (i) provide processing and distribution services for Tissue recovered by AOC and accepted by RTI; (ii) provide AOC with information indicating the extent of processed Tissue distributed in the AOC community; and (iii) provide under the Budget all supplies necessary for use by the AOC Tissue Recovery Division in procuring Tissue. Distribution representatives of RTI or any distribution partner of RTI may establish contacts with AOC Tissue Recovery Division at mutually acceptable times for information purposes including the indications and use of various Tissue products in the AOC operations area.
Xxxxxxxx, M. Sc. Ph. X. (Awarded Xxxxx Xxxxxxx and Padma Shri by President of India)
Xxxxxxxx, M. T. and Xxxxxxxxx, X., 2013. Examining the validity of a juvenile offending risk assessment instrument across gender and race/ethnicity. Youth Violence and Juvenile Justice, 11(1), pp.26-43. Xxxxxx, A.R., Xxxxxxxx, X.X., Xxxxxxxx, X.X., Xxxxxxxx, C.A., Xxxxxxx, X. and Xxxxxxxx, X.X., 2016. Validity of initial, exit, and dynamic juvenile risk assessment: An examination across gender and race/ethnicity. Journal of Offender Rehabilitation, 55(1), pp.21-38. Xxxxxxxx, X., 2015. Pro-integration: disengagement from and life after extremism. Behavioral Sciences of Terrorism and Political Aggression, 7(2), pp.129-142. Xxxxxxxxx, X.X. and Xxxxx, A.R. (2013). Applying the violent extremist risk assessment (XXXX) to a sample of terrorist case studies. Journal of Aggression, Conflict and Peace Research, 5 (1), 4-15. xxxxx://xxx.xxx/10.1108/17596591311290713 Xxxx, X.X., 2012. Gender-responsive Risk Assessment: A comparison of women and men (Doctoral dissertation, University of Cincinnati). Xxxxxx, X.X. (2017). Extremist Construction of Identity: How Escalating Demands for Legitimacy Shape and Define In-Group and Out-Group Dynamics. The International Centre for Counter- Terrorism – The Hague 8, no. 7. Xxxxxxx, X. (2007). Evidence about the link between education, poverty and terrorism among Palestinians. Peace economics, peace science and public policy, 13(1), 18-53. Xxxxx, X. (2015). Assessing Risks for Terrorism Involvement. Journal of Threat Assessment and Management, 2 (2), 63-87. Xxxxxxx, X. and Xxxxxxxx, P.O.H., 2011. Al Qaida influenced radicalization: a rapid evidence assessment guided by situational action theor y. UK Home office, Office for Security and Counter Terrorism. Vancouver
Xxxxxxxx, M. Dale, T. C., Amyloid- Associated Nucleic Acid Hybridisation. PLoS One 2011, 6 (5), e19125.
Xxxxxxxx, M. A.l Xxxxxxxx, D. S. Xxxxx, X. Xxxxxxxxx, R. Rupakhety,
Xxxxxxxx, M. S. & Xxxxxxxxxxxx X. (2001) Laboratory testing of structures under dynamic loads: an introductory review. Phil. Trans. Royal Soc. London, Series A, 359, 1651-1669.